SCHEMBL3379849

SCHEMBL3379849

CN(C)C(=O)c1cccc(N(Cc2ccccc2)S(=O)(=O)c2ccc(F)cc2)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.59
LMNA P02545 3/20 0.56
ALDH1A1 P00352 1/20 0.56
KMT2A Q03164 5/20 0.55
MEN1 O00255 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
NR3C1 P04150 1/20 0.54
ESR1 P03372 1/20 0.52
GAA P10253 1/20 0.51
HTT P42858 1/20 0.51
TAS2R14 Q9NYV8 1/20 0.50
TRPM8 Q7Z2W7 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TP53 P04637 1/20 0.50
PTGES O14684 1/20 0.49
ALOX5 P09917 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL302196 0.90 LMNA (0.61) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL2192252 0.89 LMNA (0.71) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL2189008 0.87 LMNA (0.49) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL3378326 0.85 KCNA5 (0.52) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL3379944 0.83 MAPT (0.55) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL3376926 0.83 MAPT (0.60) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL2189346 0.80 LMNA (0.85) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL302059 0.79 LMNA (0.52) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL2186013 0.78 ALDH1A1 (0.77) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL1967123 0.77 LMNA (0.68) MAPTLMNAALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342177-B1 NOVEL POTASSIUM CHANNEL BLOCKERS JAPAN TOBACCO INC (JP) 2017-02-15 EP claimed
US-8673901-B2 Potassium channel blockers XENTION LIMITED (GB) 2014-03-18 US claimed
US-20100087428-A1 Novel Potassium Channel Blockers XENTION LIMITED (GB) 2010-04-08 US claimed
EP-2342177-B1 NOVEL POTASSIUM CHANNEL BLOCKERS JAPAN TOBACCO INC (JP) 2017-02-15 EP disclosed
US-9447033-B2 Potassium channel blockers JAPAN TOBACCO INC. (JP) 2016-09-20 US disclosed
US-20150259282-A1 Potassium Channel Blockers XENTION LIMITED (GB) 2015-09-17 US disclosed
US-9073834-B2 Potassium channel blockers XENTION LIMITED (GB) 2015-07-07 US disclosed
US-20140221337-A1 Potassium Channel Blockers XENTION LIMITED (GB) 2014-08-07 US disclosed
US-8673901-B2 Potassium channel blockers XENTION LIMITED (GB) 2014-03-18 US disclosed
US-20100087428-A1 Novel Potassium Channel Blockers XENTION LIMITED (GB) 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221337-A1 Potassium Channel Blockers KCNJ2, KCNH2, KCNB1 MAPT 2884/4885LMNA 1619/4885ALDH1A1 1360/4885
US-20100087428-A1 Novel Potassium Channel Blockers HCN4, SCN2B, KCNH2 MAPT 4874/4885LMNA 2145/4885ALDH1A1 3795/4885
US-20150259282-A1 Potassium Channel Blockers KCNJ2, KCNH2, KCNB1 MAPT 2884/4885LMNA 1619/4885ALDH1A1 1360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.